Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place

Aim. To optimize chronic heart failure (CHF) pharmacotherapy, basing on endothelin (ET) system activity, functional and cardio-hemodynamic parameters, and their dynamics in beta-adrenoblocker nebivolol therapy. Material and methods. The study included 52 patients with coronary heart disease and syst...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: L. I. Olbinskaya, Yu. I. Naymann
Materyal Türü: Artigo
Dil:Russo
Baskı/Yayın Bilgisi: «SILICEA-POLIGRAF» LLC 2007-02-01
Seri Bilgileri:Кардиоваскулярная терапия и профилактика
Konular:
chronic heart failure
pulmonary hypertension
endothelin
nebivolol
Online Erişim:https://cardiovascular.elpub.ru/jour/article/view/1145
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller